LANXESS Corporation

Abstract

# 78-42-2] is being provided to OEHHA in response to its identification and subsequent consideration and review by the Carcinogen Identification Committee (CIC). LANXESS respectfully requests that these comments be reviewed by OEHHA and that they be made available to the CIC for its timely consideration at its next meeting on October 12 and 13, 2011 and in advance of its prioritization of the 39 chemicals scheduled for review at that time